| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.31B | 7.02B | 5.61B | 2.93B | 2.00B |
| Gross Profit | 797.98M | 740.59M | 811.98M | 1.16B | 1.32B |
| EBITDA | 1.39B | 900.36M | 1.07B | 1.37B | 1.59B |
| Net Income | 376.01M | 484.59M | 525.26M | 781.69M | 853.43M |
Balance Sheet | |||||
| Total Assets | 20.51B | 21.08B | 14.51B | 10.41B | 6.63B |
| Cash, Cash Equivalents and Short-Term Investments | 494.25M | 1.33B | 599.75M | 1.68B | 590.47M |
| Total Debt | 11.05B | 10.68B | 7.17B | 3.84B | 2.65B |
| Total Liabilities | 14.08B | 14.85B | 8.46B | 4.68B | 3.24B |
| Stockholders Equity | 6.25B | 6.08B | 5.92B | 5.61B | 3.39B |
Cash Flow | |||||
| Free Cash Flow | -341.92M | -3.81B | -3.47B | -761.91M | 1.21B |
| Operating Cash Flow | 1.41B | 853.80M | 964.30M | 730.48M | 1.35B |
| Investing Cash Flow | -1.27B | -4.14B | -4.30B | -3.14B | 336.47M |
| Financing Cash Flow | -125.70M | 3.10B | 3.06B | 2.51B | -1.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$66.62B | 8.26 | 11.50% | 5.43% | -16.77% | -1.46% | |
69 Neutral | HK$30.57B | 10.40 | 14.74% | 5.08% | -5.31% | 10.69% | |
65 Neutral | HK$3.40B | 6.01 | 10.60% | 5.25% | 1.17% | -0.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$20.52B | 8.52 | 7.54% | 5.82% | -16.28% | -1.83% | |
60 Neutral | HK$3.72B | 4.38 | 6.26% | 6.05% | -66.15% | -21.01% | |
55 Neutral | HK$24.21B | 8.30 | 4.88% | 3.72% | 4.71% | -4.62% |